Kymab appoints Dr Sonia Quaratino as Chief Medical Officer
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group,…
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.